1. Introduction {#sec1}
===============

The transcriptional coactivator PGC-1*α* was first identified as a coactivator of PPAR*γ* in brown adipose tissue and is now known to interact with a broad range of nuclear receptors and transcription factors to regulate mitochondrial biogenesis in most tissues but also control adaptive thermogenesis, fatty acid/glucose metabolism, ROS metabolism, and muscle fiber type switching in a tissue-specific manner \[[@B1]--[@B7]\]. The function of PGC-1*α* among tissues is regulated by signaling inputs that increase transcription of *PGC*-1*α* and modulate the transcribed protein through tissue-specific posttranslational modifications \[[@B8]--[@B14]\]. This allows PGC-1*α* to function as a key regulator to link nutritional and environmental stimuli to the tissue-specific transcriptional programs.

Alternative splicing of *PGC-1*α** produces an additional transcript that encodes a shorter isoform called NT-PGC-1*α* (aa 1--270) \[[@B15]\]. NT-PGC-1*α* is coexpressed with PGC-1*α* in metabolically active tissues and its expression is coregulated by the nutritional and environmental cues which activate the gene \[[@B15]--[@B17]\]. PGC-1*α* is a short-lived nuclear protein containing 797 amino acids. A variety of post-translational modifications enhance the stability and activity of PGC-1*α* by decreasing its targeting to the proteosome. In contrast, NT-PGC-1*α* is relatively stable since it is less effectively targeted to the proteosome due to lack of the C-terminal domain involved in proteosomal targeting \[[@B15]\]. Constitutive activation of target genes by NT-PGC-1*α* is effectively limited by a mechanism that sequesters NT-PGC-1*α* to the cytoplasm in a CRM1-dependent manner \[[@B16]\]. NT-PGC-1*α* activity is primarily modulated by increased translocation to the nucleus. PKA-dependent phosphorylation of NT-PGC-1*α* increases its nuclear retention and subsequent recruitment to the transcriptional complexes \[[@B16]\].

Another layer of regulation of PGC-1*α* function is mediated by direct interaction with other regulatory proteins. Previous studies have shown that p160^MBP^, RIP140, and Twist-1 bind to PGC-1*α* and repress its transcriptional activity. p160 myb binding protein was originally identified as a protein that interacts with the regulatory domain of PGC-1*α* (aa 200--400) in C2C12 myoblasts \[[@B18]\]. The docking of p160^MBP^ on PGC-1*α* inhibits transcription of PGC-1*α* target genes \[[@B9], [@B18]\]. RIP140 is a transcriptional corepressor for a number of nuclear receptors in adipose tissue and skeletal muscle where it represses many PGC-1*α* target genes \[[@B19]\]. Mechanistically, RIP140 directly interacts with PGC-1*α* (aa 184--797) and suppresses its activity \[[@B20]\]. Recently, the transcription factor Twist-1 was also identified as a negative regulator of PGC-1*α* in brown adipose tissue. Twist-1 is a helix-loop-helix (HLH)-containing transcription factor involved in early development, apoptosis, cancer, and osteoblast differentiation \[[@B21]--[@B23]\]. A recent study reported that Twist-1 is recruited to the PGC-1*α* target genes by docking to the C-terminal domain of PGC-1*α* (aa 350--797) to negatively modulate oxidative metabolism and UCP1-dependent uncoupling in brown adipose tissue \[[@B24]\]. Interestingly, all of these negative regulators bind to the central to C-terminal region of PGC-1*α*, suggesting that these regulators would have little or no inhibitory effect on NT-PGC-1*α* function in the nucleus.

The present study was designed to investigate the effect of known PGC-1*α* repressors on NT-PGC-1*α* function and found that Twist-1 plays a differential role in the regulation of PGC-1*α* and NT-PGC-1*α* activity in brown adipocytes. Twist-1 significantly suppressed PGC-1*α*-mediated activation of CPT1*β*, UCP1, and ERR*α* by docking to the C-terminal region of PGC-1*α*. In contrast, NT-PGC-1*α*-dependent induction of these genes was not affected by Twist-1 due to lack of interaction with Twist-1.

2. Materials and Methods {#sec2}
========================

2.1. Cell Cultures and Brown Adipocyte Differentiation {#sec2.1}
------------------------------------------------------

COS-1 cells were grown in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin (Invitrogen). Immortalized PGC-1*α*-deficient mouse brown preadipocyte cell lines expressing empty vector, PGC-1*α*, or NT-PGC-1*α* \[[@B16]\] were maintained in DMEM supplemented with 10% FBS, 1% glutamine, and 1% penicillin/streptomycin. Preadipocytes were grown to confluence in culture medium supplemented with 20 nM insulin and 1 nM T3 (differentiation medium). Differentiation of brown adipocytes was induced (day 1) by incubating the cells in differentiation medium supplemented with 0.5 mM isobutylmethylxanthine (IBMX), 0.5 *μ*M Dexamethasone, and 0.125 mM indomethacin for 48 hours. Thereafter, the cells were maintained in differentiation medium until day 7, followed by treatment with dibutyryl cAMP for 4 h.

2.2. Luciferase Reporter Assay {#sec2.2}
------------------------------

COS-1 cells were transiently transfected using Fugene6 (Roche) with following plasmids. For a transcriptional repression assay with RIP140, GAL4-responsive luciferase reporter (pGK), GAL4-DBD-fused mouse ERR*α*-LBD, and plasmids expressing PGC-1*α*-HA, NT-PGC-1*α*-HA, and RIP140 were used. For a transcriptional repression assay with Twist-1, (PPRE)~3~-TK-luc, pSV sport-PPAR*γ*1, and plasmids expressing PGC-1*α*-HA, NT-PGC-1*α*-HA, and Twist-1 were used. pRL-SV40 control plasmid expressing *Renilla* luciferase was used for normalization. Cells were harvested for luciferase assay 48 h after transfection, and luciferase activity was determined using a Promega Dual Luciferase assay kit (Promega). The firefly luciferase activity was normalized with *Renilla* luciferase activity. Data represent mean ± SEM of at least four independent experiments.

2.3. Immunoprecipitation and Western Blot {#sec2.3}
-----------------------------------------

COS-1 cells were transfected with pcDNA3.1-Flag-Twist-1 and pcDNA3.1-PGC-1*α*-HA or pcDNA3.1-NT-PGC-1*α*-HA. Cells were harvested 48 h after transfection, washed with ice-cold PBS, and lysed in IP buffer (20 mM HEPES-NaOH, pH 7.0, 150 mM NaCl, 0.2% NP-40) supplemented with a protease inhibitor cocktail (Roche). Lysates were precleared with protein G-agarose beads and immunoprecipitated with IgG and anti-Flag antibody (Sigma) overnight at 4°C. After washings, immunoprecipitates were subjected to Western blot analysis using anti-PGC-1*α* antibody directed against the N-terminus of PGC-1*α* (aa 1--200) and anti-Flag antibody.

2.4. Retroviral Infection {#sec2.4}
-------------------------

GP-293 cells were cotransfected with pVSV-G and pBABE-zeo or pBABE-zeo-Twist-1 using Profection transfection system (Promega). Following transfection, the cells were incubated at 32°C to increase viral titer. Virus-containing medium was collected, filtered through the 0.45 *μ*m filter, and used to infect target cells. Immortalized PGC-1*α-*deficient mouse brown preadipocyte cells that ectopically express empty vector, PGC-1*α*, or NT-PGC-1*α* \[[@B16]\] were infected with the viral supernatant supplemented with 8 *μ*g/mL polybrene. The medium was aspirated after 2 h and replaced with fresh viral supernatant, and the procedure was repeated. After 8 h of infection, the cells were replaced with fresh DMEM medium supplemented with 10% FBS, 1% glutamine, and 1% penicillin/streptomycin. Selection was initiated with zeocin (Invitrogen) 48 h after infection.

2.5. Real-Time PCR Analysis {#sec2.5}
---------------------------

Total RNA was isolated from brown adipocytes using Tri-Reagent (Molecular Research Center) and RNeasy kits (Qiagen). For quantitative RT-PCR analysis, 2 *μ*g of RNA samples were reverse transcribed using oligo dT primers and M-MLV reverse transcriptase (Promega), and 4 ng of cDNA were used in quantitative PCR reactions in the presence of a fluorescent dye (Cybergreen, Takara) on Applied Biosystems 7900 (Applied Biosystems). Relative abundance of mRNA was normalized to that of cyclophilin mRNA. The primers for Twist-1, UCP1, CPT1*β*, Cox7a1, ERR*α*, VLCAD, PPAR*α*, and cyclophilin were previously described \[[@B15], [@B16], [@B24]\].

3. Results {#sec3}
==========

3.1. Twist-1 Negatively Regulates PGC-1*α* but Not NT-PGC-1*α* {#sec3.1}
--------------------------------------------------------------

Brown adipose tissue expresses two PGC-1*α* isoforms (PGC-1*α* and NT-PGC-1*α*), both of which regulate transcription of mitochondrial and thermogenic genes by promoting the activity of several nuclear receptors including PPARs \[[@B15]--[@B17]\]. RIP140 and Twist-1, which have been shown to negatively regulate PGC-1*α* activity in adipose tissue, were tested for their effect on regulation of NT-PGC-1*α* function. NT-PGC-1*α* (aa 1--270) partially contains a docking region for RIP140 that binds to the wide region of PGC-1*α* (aa 186--797), whereas the C-terminal Twist-1-binding domain (aa 353--797) is missing in NT-PGC-1*α* ([Figure 1(a)](#fig1){ref-type="fig"}). To assess the ability of these transcriptional regulators to modulate NT-PGC-1*α* activity, we carried out transient co-transfection and luciferase reporter assays as described in Materials and Methods. For a transcriptional repression assay with RIP140, Gal4-DBD-fused ERR*α*-LBD was used since RIP140 in part decreases transcriptional activity of full length ERR*α* \[[@B25]\]. The transcriptional activity of Gal4-ERR*α*-LBD was not affected by RIP140 (data not shown). Co-expression of RIP140 with PGC-1*α* significantly inhibited the ability of PGC-1*α* to increase Gal4-ERR*α*-LBD-mediated transcription of the reporter gene ([Figure 1(b)](#fig1){ref-type="fig"}). Similarly, RIP140 suppressed NT-PGC-1*α*-mediated induction of the reporter gene ([Figure 1(b)](#fig1){ref-type="fig"}), indicating that amino acids 186--270 in NT-PGC-1*α* are sufficient for RIP140 binding and repression. A transcriptional repression assay with Twist-1 showed that Twist-1 largely suppressed the ability of PGC-1*α* to increase PPAR*γ*-mediated transcription, whereas NT-PGC-1*α*-dependent increase of reporter gene expression was not affected by Twist-1 ([Figure 1(c)](#fig1){ref-type="fig"}).

3.2. Twist-1 Does Not Interact with NT-PGC-1*α* {#sec3.2}
-----------------------------------------------

Twist-1 suppresses PGC-1*α* activity by docking to the C-terminal domain of PGC-1*α* ([Figure 1](#fig1){ref-type="fig"}) \[[@B24]\]. To test that no repression of NT-PGC-1*α* activity by Twist-1 is due to lack of interaction between two proteins, Flag-Twist-1 was co-expressed with PGC-1*α*-HA or NT-PGC-1*α*-HA in COS-1 cells and immunoprecipitated with IgG and anti-Flag antibody. PGC-1*α* was efficiently coprecipitated with Twist-1 but not with IgG control ([Figure 2(a)](#fig2){ref-type="fig"}). In contrast, NT-PGC-1*α* was not coimmunoprecipitated with Twist-1 ([Figure 2(b)](#fig2){ref-type="fig"}), suggesting that Twist-1 is not recruited to NT- PGC-1*α* target genes.

3.3. Twist-1 Differentially Regulates a Subset of PGC-1*α*- and NT-PGC-1*α*-Target Genes in Brown Adipocytes {#sec3.3}
------------------------------------------------------------------------------------------------------------

Twist-1 is selectively expressed in adipose tissue and its overexpression in brown adipocytes specifically suppresses PGC-1*α*-mediated activation of fatty acid oxidation and uncoupling genes \[[@B24]\]. Since NT-PGC-1*α* is co-expressed with PGC-1*α* in brown adipocytes and regulates many PGC-1*α* target genes \[[@B15]--[@B17]\], we hypothesized that PGC-1*α* and NT-PGC-1*α* are differently regulated by Twist-1 in brown adipocytes. To investigate a differential role of Twist-1 in PGC-1*α*- and NT-PGC-1*α*-target gene expression in brown adipocytes, the *PGC-1*α**-deficient mouse brown preadipocyte cell lines expressing empty vector, PGC-1*α*, or NT-PGC-1*α* \[[@B16]\] were transduced with Twist-1 retrovirus to overexpress Twist-1. PPAR expression is not affected by PGC-1*α* or NT-PGC-1*α* \[[@B26]\]. In addition, Twist-1 does not change PPAR expression or activity \[[@B24]\]. After retroviral infection, the mRNA levels of Twist-1 were \~16- and \~12-fold increased in the *PGC-1*α**-deficient brown preadipocytes expressing PGC-1*α* and NT-PGC-1*α*, respectively ([Figure 3](#fig3){ref-type="fig"}).

These brown preadipocyte cell lines were then differentiated for 7 days and treated with dibutyryl cAMP to maximize protein stability/activity of PGC-1*α* and increase nuclear retention of NT-PGC-1*α* \[[@B15], [@B16]\]. In response to cAMP-induced signaling, p38 MAPK increases stabilization and activation of PGC-1*α* protein by preventing its proteosomal targeting \[[@B8]\], whereas cAMP-activated PKA phosphorylates NT-PGC-1*α*, leading to inhibition of CRM1-mediated nuclear export \[[@B16]\]. Expression of aP2, a marker of adipocyte differentiation, was relatively comparable among the cell lines ([Figure 4(a)](#fig4){ref-type="fig"}). In agreement with previous findings \[[@B24]\], overexpression of Twist-1 in differentiated brown adipocytes significantly suppressed PGC-1*α*-mediated induction of CPT1*β*, UCP1, and ERR*α*, which are implicated in mitochondrial fatty acid oxidation and uncoupling ([Figure 4(b)](#fig4){ref-type="fig"}). In contrast, Twist-1 had no suppressive effect on NT-PGC-1*α*-dependent induction of CPT1*β*, UCP1, and ERR*α* ([Figure 4(b)](#fig4){ref-type="fig"}), indicating that Twist-1 differently regulates PGC-1*α* and NT-PGC-1*α* activity in brown adipocytes. With no addition of dibutyryl cAMP, PGC-1*α* and NT-PGC-1*α* are able to activate their target gene expression although their transcriptional activity is reduced. In the absence of cAMP signaling activation, cAMP-dependent increase of basal UCP1 levels was \~80% reduced, leading to large fold changes in PGC-1*α*- and NT-PGC-1*α*-mediated induction of UCP1 (12.2-fold and 10.3-fold, respectively) (Figure S1, available online at doi: 10.1155/2012/320454). Similarly, Twist-1 significantly suppressed PGC-1*α*-mediated induction of UCP1, whereas NT-PGC-1*α*-mediated increase of UCP1 gene expression was not affected by Twist-1 (Figure S1, available online at doi: 10.1155/2012/320454). Expression of many mitochondrial genes and nuclear receptors is also regulated by PGC-1*α* and NT-PGC-1*α* \[[@B15]--[@B17]\]. However, neither PGC-1*α*- nor NT-PGC-1*α*-dependent induction of Cox7a1, PPAR*α*, and VLCAD ([Figure 4(c)](#fig4){ref-type="fig"}) and MCAD, Atp5b (not shown) was affected by Twist-1. This suggests that Twist-1 negatively regulates only a subset of PGC-1*α* target genes in brown adipocytes.

4. Discussion {#sec4}
=============

We previously reported that PGC-1*α* and NT-PGC-1*α* regulate a number of mitochondrial and thermogenic genes in brown adipose tissue \[[@B15]--[@B17]\]. Sympathetic stimulation of BAT by cold increases transcription of the *PGC-1*α** gene by activating and recruiting cAMP-dependent transcription factors, ATF2 and CREB, to the *PGC-1*α** promoter \[[@B1], [@B27]\]. Subsequent normal and alternative splicings of the transcribed RNA produce comparable mRNA levels of PGC-1*α* and NT-PGC-1*α*, respectively \[[@B15]\]. However, two transcripts produce structurally different proteins that possess fundamental differences in their protein size, stability, and localization. These different natures of two PGC-1*α* isoforms require different regulatory mechanisms to increase their transcriptional activity in response to the same signaling inputs. For example, cold/cAMP-activated p38 MAPK phosphorylation leads to stabilization and activation of PGC-1*α* protein by preventing its proteosomal targeting \[[@B8]\]. In contrast, cAMP-activated PKA phosphorylation increases nuclear accumulation of NT-PGC-1*α* and subsequent recruitment to the transcriptional complexes \[[@B16]\].

Here we show an additional regulatory mechanism that differently modulates transcriptional activity of PGC-1*α* and NT-PGC-1*α* in the nucleus of brown adipocytes. The mode of action is mediated by direct interaction of PGC-1*α* with a negative regulator Twist-1, which is abundantly expressed in brown adipocytes. Twist-1 is recruited to PGC-1*α* target genes by docking to the C-terminal region of PGC-1*α* and inhibits their expression by subsequently recruiting the histone deacetylase HDAC5 to the PGC-1*α* target gene promoters (e.g., UCP1 and CPT1) \[[@B24]\]. In contrast, Twist-1 has no inhibitory effect on NT-PGC-1*α*-mediated induction of NT-PGC-1*α* target genes since NT-PGC-1*α* does not recruit Twist-1 to its target gene promoters. Despite potential inhibition of all PGC-1*α* target genes by Twist-1, Twist-1 suppresses only a subset of PGC-1*α* target genes, including UCP1, CPT1*β*, and ERR*α*. Twist-1 is a basic helix-loop-helix (bHLH)-containing transcription factor that binds to the canonical E-box and the related sequences in the regulatory regions of target genes \[[@B28]\], thus raising a possibility that the presence of potential E-boxes on the PGC-1*α* target gene promoters further specifies a subset of PGC-1*α*/Twist-1 target genes. However, it seems unlikely that subsequent docking of Twist-1 to the potential E-boxes on the PGC-1*α* target gene promoters is required for its inhibitory effect since Twist-1-mediated suppression does not depend on its DNA-binding activity \[[@B24]\]. Instead, Twist-1 exerts its transcriptional repression on PGC-1*α* target genes by altering chromatin conformational states by recruitment of histone deacetylases (HDAC) \[[@B24]\]. Thus, it is likely that subsequent recruitment of additional regulators (e.g., histone deaceylases) to the PGC-1*α* target gene promoters by Twist-1 is required for its suppression of PGC-1*α*-mediated gene expression.

5. Conclusion {#sec5}
=============

Our findings demonstrate a differential regulation of PGC-1*α* and NT-PGC-1*α* activity by Twist-1 in brown adipocytes. Twist-1 suppresses PGC-1*α*-mediated transcriptional activation of a subset of PGC-1*α* target genes, including UCP1, CPT1*β*, and ERR*α*. In contrast, NT-PGC-1*α*-mediated induction of these genes is not affected by Twist-1.

Supplementary Material {#supplementary-material-sec}
======================

###### 

Figure S1. Differential effect of Twist-1 on PGC-1*α*- and NT-PGC-1*α*-dependent induction of UCP1.

Quantitative real time PCR analysis of gene expression in differentiated PGC-1*α*-null brown adipocytes expressing empty vector (pBABE), PGC-1*α*, and NT-PGC-1*α* in the absence (white bars) or presence of Twist-1 (black bars). Differentiated brown adipocytes were collected without treatment with dibutyryl cAMP. Relative abundance of mRNA levels was normalized to that of cyclophilin mRNA. Data represent mean ± SEM of at least four independent experiments. ∗∗∗∗,p \< 0.0001; ns, not significant.

###### 

Click here for additional data file.
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![Effects of transcriptional regulators on PGC-1*α* and NT-PGC-1*α* function. (a) Schematic diagram of PGC-1*α* and NT-PGC-1*α* proteins. L1, L2, and L3 represent leucine-rich motifs, one of which (L2) bears the conserved LXXLL sequence that interacts with nuclear receptors. Two white boxes represent the interaction regions of PGC-1*α* with transcriptional regulators, Twist-1, and RIP140, respectively. (b), (c) Transcriptional repression assay using a luciferase reporter. pcDNA3.1, PGC-1*α*, and NT-PGC-1*α* were cotransfected in COS-1 cells with Gal4-ERR*α*-LBD and RIP140 (b) or PPAR*γ* and Twist-1 (c). Luciferase activity was determined 48 h after transfection and the relative luciferase units were calculated as described in Materials and Methods. Data represent mean ± SEM of at least three independent experiments. Significant difference is determined by student *t*-test (\*\**P* \< 0.01; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001; ns: not significant).](PPAR2012-320454.001){#fig1}

![Interactions of Twist-1 with PGC-1*α* but not with NT-PGC-1*α*. PGC-1*α*-HA (a) and NT-PGC-1*α*-HA (b) were co-expressed with Flag-Twist-1 in COS-1 cells. Immunoprecipitates with IgG or anti-Flag antibody were separated by SDS-PAGE and immunoblotted with anti- PGC-1*α* (a, top panel) or HA antibody (b, top panel). Expression of Flag-Twist-1 was confirmed by probing with anti-Flag antibody (a and b, bottom panels).](PPAR2012-320454.002){#fig2}

![The elevated Twist-1 levels in brown preadipocytes by retroviral infection. Immortalized PGC-1*α-*deficient brown preadipocyte cells that express pBABE-neo vector, PGC-1*α*, or NT-PGC-1*α* were transduced with pBABE-zeo or Twist-1 retrovirus. Zeocine-resistant cells were pooled and Twist-1 expression was assessed by real time-PCR analysis. Relative abundance of Twist-1 mRNA was normalized to that of cyclophilin mRNA.](PPAR2012-320454.003){#fig3}

![Differential effect of Twist-1 on PGC-1*α* and NT-PGC-1*α* target gene expression in brown adipocytes. (a), (b), (c) Quantitative real time PCR analysis of gene expression in differentiated PGC-1*α-*null brown adipocytes expressing empty vector (pBABE), PGC-1*α*, and NT-PGC-1*α* with empty vector (white bars) or Twist-1 (black bars). Relative abundance of mRNA levels was normalized to that of cyclophilin mRNA. Data represent mean ± SEM of at least four independent experiments. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001; \*\*\*\**P* \< 0.0001; ns: not significant.](PPAR2012-320454.004){#fig4}
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